Search

Author/Creator Braulke, F.

1. Significance of Molecular and Cytogenetic TP53 Status in MDS with Complex Karyotypes. (April 2017)

Authors:
Ganster, C.; Schaab, R.; Shirneshan, K.; Dierks, S.; Martin, R.; Germing, U.; Palomo, L.; Mies, A.; Cisneros, A.; Braulke, F.; Hildebrandt, B.; Kaivers, J.; Platzbecker, U.; Kroeger, N.; Doehner, K.; Glass, B.; Nickelsen, M.; Schanz, J.; Bacher, U.; Haase, D.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): INITIALLY AND NEWLY ACQUIRED TP53 MUTATIONS IN PATIENTS WITH MDS WITH DEL(5Q) WITH/WITHOUT LENALIDOMIDE. (May 2023)

Authors:
Ganster, C.; Eder, L.; Rittscher, K.; Brzuszkiewicz, E.; Braulke, F.; Glass, B.; Elmaagacli, A.; Mazzeo, P.; Shirneshan, K.; Haase, D.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search